Production of anticancer polyenes through precursor-directed biosynthesis.

Area of Science:

• Natural Product Chemistry
• Medicinal Chemistry
• Mycology

Background:

• The fungal metabolite rumbrin's pyrrolyl moiety is derived from pyrrole-2-carboxylic acid.
• Exploring structural modifications of natural products can lead to compounds with improved biological activities.

Purpose of the Study:

• To synthesize novel rumbrin derivatives with potentially enhanced biological activity.
• To investigate the incorporation of halogenated pyrrole-2-carboxylates into the rumbrin structure.
• To evaluate the cytotoxicity of the synthesized derivatives against cancer cell lines.

Main Methods:

• Synthesis of substituted pyrrole-2-carboxylates, including 4-halo-pyrrole-2-carboxylic acids.
• Incubation of synthesized compounds with the producing organism, Auxarthron umbrinum.
• Isolation and characterization of new rumbrin derivatives (isorumbrins).
• Cytotoxicity assays using HeLa and A549 (lung cancer) cell lines.

Main Results:

• Three new isorumbrin derivatives were synthesized: 3-fluoro-, 3-chloro-, and 3-bromo-isorumbrin.
• The 3-chloro- and 3-bromo-isorumbrins exhibited increased cytotoxicity against HeLa cells compared to rumbrin.
• 3-bromoisorumbrin demonstrated significantly enhanced activity against the A549 lung cancer cell line.

Conclusions:

• Halogenation of pyrrole-2-carboxylic acid is a viable strategy for generating rumbrin derivatives with improved anticancer properties.
• 3-bromoisorumbrin is a promising candidate for further investigation as an anticancer agent, particularly for lung cancer.
• This study expands the chemical diversity of fungal metabolites and provides leads for novel chemotherapeutic development.